Flarin’s unique Lipid Lock® technology which delivers powerful relief from joint pain and inflammation
A double-blind, randomised, multi-centre clinical trial of episodic knee pain (FLARE study), published in Osteoarthritis and Cartilage ), showed combining ibuprofen in a lipid formulation (Flarin 200 mg soft capsules ,1200 mg/day) delivered effective relief of knee pain.
Flarin lipid formulated ibuprofen (1200mg/day) has been shown to be as effective as twice the dose (2400mg/day) of standard ibuprofen.
No other ibuprofen has been proven to be more effective for joint pain.
Flarin is absorbed in the small intestine.